Dave Ferrera

David Ferrera is an engineer, entrepreneur, inventor and advisor with nearly 30 years of experience in the medical device field successfully developing products, founding companies, and managing them from concept through commercialization. He’s author of Innovation in Translation - How Big Ideas Really Happen Published by Advantage-Forbes in 2021.

He’s currently General Partner of Treadstone Holdings, a newly formed medical device venture studio that is funding, designing, developing and commercializing products for the interventional radiology markets. Treadstone Medical works with physician-entrepreneurs to identify new product technology and indications of medical devices. Treadstone Holdings is presently forming newcos with physicians to create product-based solutions for solutions they encounter every day in the interventional suite.

He was formerly Chief Technology Officer of Balt Global (France) which is dedicated to advancing therapies in hemorrhagic and ischemic stroke. David co-founded Blockade Medical in 2011 and was their President and CEO. Blockade was acquired by Balt Extrusion of France in August 2016. Balt designs, manufactures and distributes 'Interventional Neuro Radiology’ (‘INR’) devices such as catheters, stents and coils that are essential in treating such conditions as hemorrhagic and ischemic stroke.

Prior to co-founding Blockade he was Vice President of Product Development/Clinical Research/General Manager of MindFrame Inc., of Irvine, CA. Mr. Ferrera formed and managed the team that successfully developed the company’s first acute stroke mechanical thrombectomy product line. MindFrame was acquired by Covidien/ev3 Neurovascular (now Medtronic Neurovascular) in 2012.

Previously, Mr. Ferrera was Director of Clinical Research/R&D at Microvention Inc., a subsidiary of Terumo Corporation (Japan). Microvention was acquired by Terumo in 2006. Prior to that, he was co-founder and Director of Technology Development at Micrus Endovascular. Micrus Endovascular was acquired by J&J (now Cerenovus) in 2010. Mr. Ferrera also held engineering and R&D positions with Boston Scientific in Watertown, MA and IMPRA, Inc., of Tempe, AZ, a subsidiary of Bard.

Mr. Ferrera is on several boards; Innervate Medical (co-founder), Vasometrics Medical (co-founder), Mehana Medical (co-founder), SAGE Orange County, Spinal Singularity and American Heart and Stroke Association – Orange County. He was the 2020 Chair for the Heart & Stroke Ball and presently the 2021 Chair for Heart & Stroke Ball.

Mr. Ferrera holds a Bachelors of Science Degree in Plastics Engineering from University of Lowell, Massachusetts. He is an alumnus of UMass Lowell Baseball. He also holds 80+ US and International patents for medical devices.